Business Context and Reporting Period
This Form 8-K was filed by Dice Holdings, Inc. on September 24, 2012. The report discloses the appointment of a new member to the Company's Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Golnar Sheikholeslami as a Class II director to the Board of Directors. Ms. Sheikholeslami brings experience as Executive Vice President and Chief Product Officer of Everyday Health, Inc., and previously held senior roles at The Washington Post and Condé Nast.
Compensation and Governance Details
- Annual Fee: Ms. Sheikholeslami will receive an annual Board fee of $30,000 as an independent director.
- Equity Grant: She will be granted 10,000 restricted shares of common stock under the 2012 Omnibus Equity Award Plan.
- Vesting Schedule: The restricted shares will vest one year after issuance, contingent upon her continued service on the Board.
Investor Verification Checklist
- Verify the total number of outstanding shares to assess the dilution impact of the 10,000 restricted share grant.
- Review the Company's proxy statement dated March 14, 2012, for full details on non-employee director compensation components.
- Confirm the effective date of the Board appointment and the specific class designation (Class II).